FDA Approved (Spravato 2019)
Ketamine Therapy
FDA-approved for treatment-resistant depression via the nasal spray Spravato (esketamine). Ketamine clinics are available nationwide offering both IV infusions and the FDA-approved formulation.
50Clinical Trials
0Companies
0Legal States
FDA StatusFDA Approved (Spravato 2019)
Legal PathwayAlready legal via prescription
Also Known AsSpravato, esketamine, ketamine infusion
Clinical Trials
10 trials currently recruiting
Phase 19
Phase 25
Phase 33
Unknown·N/A·ketamine
Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia
King Saud University
AnemiaCardiomyopathiesPulmonary Hypertension
Completed·N/A·Other
Analgesic Efficacy of US-Guided Interscalene Block Versus Supraclavicular Block for Ambulatory Arthroscopic Rotator Cuff Repair
Ramsay Générale de Santé
Shoulder Lesions
Withdrawn·Phase 4·ketamine
A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients
University of Colorado, Denver
Thermal HyperalgesiaAnxietyPain
Recruiting·N/A·ketamine
Ketamine for Preventing Post-Spinal Hypotension in Orthopedic Surgery
Ain Shams University
Post-spinal HypotensionOrthopedic SurgerySpinal Aneshtesia
Withdrawn·Phase 2·ketamine
Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study
Zylorion Health
Treatment Resistant Major Depressive Disorder
Terminated·N/A·Other
Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer
Kantonsspital Winterthur KSW
Breast Cancer, Invasive Ductal
Companies & Research
Organizations developing Ketamine-based therapies
No companies found
We don't have company data for Ketamine yet.